Skip to main content
. 2022 Jan 26;9:806966. doi: 10.3389/fmolb.2022.806966

FIGURE 6.

FIGURE 6

Model of ranolazine for the treatment of diabetic cardiac fibrosis by upregulating miR-135b to inhibit fibroblast pyroptosis and reduce collagen deposition.